This message was sent to ##Email##
|
|
|
|
|
AST
Join us for an interactive discussion on organ allocation at the 2020 Cutting Edge of Transplantation (CEoT) meeting in Phoenix, AZ. Register and book your housing today.
READ MORE
AST
In December 2019, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019, also known as the Immuno Bill, was introduced in the House of Representatives. This legislation would extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients, which is currently limited to just 36 months. Contact Congress Today
AST
Visit the AST Member Spotlight page to learn about Gwen McNatt's extended service to the AST.
Interested in being featured in the AST Member Spotlight? Please contact rpaulin@myast.org for more information.
READ MORE
 |
|
Promoted by
Veloxis Pharmaceuticals
Now you can see the different ways that different formulations are released and absorbed in the gastrointestinal system. You’ll also have the opportunity to explore comparative pharmacokinetic results in rapid metabolizers, efficacy data over 2 years, and safety information.
Watch Video
|
|
AST
The AST’s Trainee and Young Faculty COP created a brand-new user guide for new AST members. If you are a new AST member, or if you would like to learn more, this guide will help you get the most out of your membership.
READ MORE
AST
OPTN/UNOS released 11 proposals for public comment on January 22, 2020. The AST's Communities of Practice will be providing feedback to the Policy Committee and Board for Society responses to these requests. Public comment is open to all. Members are encouraged to share their feedback through their COPs and/or as individuals on the OPTN website. If you wish for your individual comments to be considered alongside COP feedback by the Board, please submit them to info@myast.org by February 25. The comment period will close on March 24.
READ MORE
Advertisement
EnvarsusXR
Did you know there’s a transplant support system to help patients and providers with best-in-class assistance and resources? This ongoing support system assists with benefit investigation, prior authorization assistance, coordination with specialty pharmacies, prescription fulfillment navigation, and CoverMyMeds® access. There’s also a $0 co-pay card to overcome financial barriers.
Find out more
|
AST
This year’s CMS Quality Conference has sessions focused on Fostering Innovation in Kidney health, ESRD, and increasing transplantation. CMS will have a specific track of sessions focused on the ETC Kidney Transplant Learning Collaborative where participants will discuss the Learning Collaborative goals to increase kidney transplantation, share best practices to increase kidney utilization and donation, and provide exposure to cutting edge issue discussions, accountability actions and a thoughtful, disciplined approach to improvement.
Kidney Transplant Programs are key to the process. This important work requires your leadership engagement and focus to generate results. CMS and HRSA are asking for our proactive sponsorship and support of these bold aims.
Please attend this meeting and bring your transplant colleagues to generate excitement and commitments as we relentlessly advocate for spreading best practices in order to achieve results.
- Bring at least 1 representative from your transplant program
- Invite at least 1-2 representatives from your OPO to team with you
- Invite representatives from large trauma hospitals to team with you
The CMS Quality Conference, brought to you by the Centers for Medicare & Medicaid Services, will convene 3,000 leaders across the health care spectrum, to explore how patients, advocates, providers, researchers, and champions in health care quality improvement can develop and spread solutions to address America’s most pervasive health system challenges. Participants will experience interactive learning sessions, master classes for continuing education credit, and engaging seminars and keynote addresses spanning vast areas.
READ MORE
AST
The Transplantation Society in collaboration with the American Society of Transplantation (AST), acknowledges the contribution of basic science to the field of transplantation by offering Mentee-Mentor awards. The International Transplantation Science Mentee-Mentor Awards aim is to encourage young investigators to submit their research to TTS 2020 and help cover expenses to attend the Congress in Seoul. For more information about the awards and eligibility, click here.
|
|
AST
The Transplant Nephrology Core Curriculum (TNCC) is an online program jointly provided by the American Society of Nephrology and the American Society of Transplantation. The TNCC focuses on key information needed to prepare for the American Board of Internal Medicine Nephrology Board Certification and Maintenance of Certification examinations.
READ MORE
AST
Transplant professionals have increasing demands on their time. Finding time in one’s day to attend conferences or to read journals is challenging. Transplant in 10 is intended to provide transplant professionals with short, easily accessible videos on key and updated topics in 10 minutes.
READ MORE
|
TruGraf® - The 1st and only non-invasive test to rule out “silent" subclinical rejection in stable kidney transplant recipients
The only test to be reimbursed as an alternative to surveillance biopsies
Developed by Clinicians for Clinicians
Learn More
|
|
|
|
|
Reach Your Prospects Every Week
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
| | UPCOMING EDUCATION EVENTS |
February 18, 2020 | 2 pm ET | Online Activity
For more information, click here
March 24, 2020 | 2 pm ET | Online Activity
For more information, click here.
|
|
American Journal of Transplantation via Wiley Online Library
The Scientific Registry of Transplant Recipients uses data collected by Organ Procurement and Transplantation Network to calculate metrics such as donation rate, organ yield, and rate of organs recovered for transplant but not transplanted. In 2018, there were 10,721 deceased donors, and this number has been increasing since 2010. The number of deceased donor transplants increased to 29,676 in 2018 from 28,582 in 2017, and this number has been increasing since 2012.
READ MORE
American Journal of Transplantation via Wiley Online Library
Uncontrolled donation after cardiac death (uDCD) has the potential to ameliorate the shortage of suitable lungs for transplantation. To date, no lung transplantation data from these donors is available from North America. Herein we describe the successful use of these donors using a simple method of in situ lung inflation so that the organ can be protected from warm ischemic injury. Forty‐four potential donors were approached, and family consent was obtained in 30 cases (68%).
READ MORE
American Journal of Transplantation via Wiley Online Library
Regulatory T cells (Tregs) are a lymphocyte subset with intrinsic immunosuppressive properties that can be expanded in large numbers ex vivo and have been shown to prevent allograft rejection and promote tolerance in animal models. To investigate the safety, applicability and biological activity of autologous Treg adoptive transfer in humans, we conducted an open‐label, dose‐escalation, Phase I clinical trial in liver transplantation.
READ MORE
American Journal of Transplantation via Wiley Online Library
The practice of transplanting hepatitis C (HCV)‐infected livers into HCV‐uninfected recipients has not previously been recommended in transplant guidelines, in part because of concerns over uncontrolled HCV infection of the allograft. Direct‐acting antivirals (DAAs) provide an opportunity to treat donor‐derived HCV‐infection and should be administered early in the posttransplant period. However, evidence on the safety and efficacy of an immediate DAA treatment approach, including how to manage logistical barriers surrounding timely DAA procurement, are required prior to broader use of HCV‐positive donor organs.
READ MORE
American Association for the Study of Liver Diseases
Recipients of simultaneous liver‐kidney transplants (SLKT) have a lower risk of rejection compared with recipients of kidney transplants alone. However, there is disagreement about the impact of pre‐transplant anti‐HLA sensitization on patient and kidney graft survival in the long‐term. The aim of the study was to evaluate the impact of the recipient immunological risk and comorbidities in renal graft outcome on SLKT.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
